Chiara Mandò

Prof. Chiara Mandò

Università degli Studi di Milano - Department of Biomedical & Clinical Sciences "L. Sacco"
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2014 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CMChiara Mandò
Chiara Mandò
Clara De PalmaClara De Palma
Clara De Palma
TSTamara Stampalija
Tamara Stampalija
GAG. M. Anelli
G. M. Anelli
MFM. Figus
M. Figus
ICIrene Cetin
Irene Cetin
Intrauterine growth restriction (IUGR) and pregnancy hypertensive disorders such as preeclampsia (PE) associated with IUGR share a common placental phenotype called “placental insufficiency”, originating in early gestation when high availability of energy is required. Here, we assess mitochondrial content and the expression and activity of respiratory chain complexes (RCC) in placental cells of these pathologies. We measured mitochondrial (mt)DNA and nuclear respiratory factor 1 ( NRF1) expression in placental tissue and cytotrophoblast cells, gene and protein expressions of RCC (real-time PCR and Western blotting) and their oxygen consumption, using the innovative technique of high-resolution respirometry. We analyzed eight IUGR, six PE, and eight uncomplicated human pregnancies delivered by elective cesarean section. We found lower mRNA levels of complex II, III, and IV in IUGR cytotrophoblast cells but no differences at the protein level, suggesting a posttranscriptional compensatory regulation. mtDNA was increased in IUGR placentas. Both mtDNA and NRF1 expression were instead significantly lower in their isolated cytotrophoblast cells. Finally, cytotrophoblast RCC activity was significantly increased in placentas of IUGR fetuses. No significant differences were found in PE placentas. This study provides genuine new data into the complex physiology of placental oxygenation in IUGR fetuses. The higher mitochondrial content in IUGR placental tissue is reversed in cytotrophoblast cells, which instead present higher mitochondrial functionality. This suggests different mitochondrial content and activity depending on the placental cell lineage. Increased placental oxygen consumption might represent a limiting step in fetal growth restriction, preventing adequate oxygen delivery to the fetus.

16 May 2010 in Epigenetics
Verified
Journal Article
Closed access
STSilvia Maria Tabano
Silvia Maria Tabano
PCPatrizia Colapietro
Patrizia Colapietro
ICIrene Cetin
Irene Cetin
FGFrancesca R. Grati
Francesca R. Grati
SZSusanna Zanutto
Susanna Zanutto
MMMonica Miozzo
Monica Miozzo
Genomic imprinting, resulting in parent-of-origin-dependent gene expression, is mainly achieved by DNA methylation. IGF2 and H19, belonging to the same cluster of imprinted genes and regulated by I...

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CMChiara Mandò
Chiara Mandò
GAGaia Maria Anelli
Gaia Maria Anelli
CNChiara Novielli
Chiara Novielli
PPPaola Panina-Bordignon
Paola Panina-Bordignon
MMMaddalena Massari
Maddalena Massari
ICIrene Cetin
Irene Cetin
A lipotoxic placental environment is recognized in maternal obesity, with increased inflammation and oxidative stress. These changes might alter mitochondrial function, with excessive production of reactive oxygen species, in a vicious cycle leading to placental dysfunction and impaired pregnancy outcomes. Here, we hypothesize that maternal pregestational body mass index (BMI) and glycemic levels can alter placental mitochondria. We measured mitochondrial DNA (mtDNA, real‐time PCR) and morphology (electron microscopy) in placentas of forty‐seven singleton pregnancies at elective cesarean section. Thirty‐seven women were normoglycemic: twenty‐one normal‐weight women, NW, and sixteen obese women, OB/GDM(−). Ten obese women had gestational diabetes mellitus, OB/GDM(+). OB/GDM(−) presented higher mtDNA levels versus NW, suggesting increased mitochondrial biogenesis in the normoglycemic obese group. These mitochondria showed similar morphology to NW. On the contrary, in OB/GDM(+), mtDNA was not significantly increased versus NW. Nevertheless, mitochondria showed morphological abnormalities, indicating impaired functionality. The metabolic response of the placenta to impairment in obese pregnancies can possibly vary depending on several parameters, resulting in opposite strains acting when insulin resistance of GDM occurs in the obese environment, characterized by inflammation and oxidative stress. Therefore, mitochondrial alterations represent a feature of obese pregnancies with changes in placental energetics that possibly can affect pregnancy outcomes.

1 February 2016 in Placenta
Verified
Journal Article
Closed access
CMChiara Mandò
Chiara Mandò
SCStefania Calabrese
Stefania Calabrese
MMMartina Ilaria Mazzocco
Martina Ilaria Mazzocco
CNChiara Novielli
Chiara Novielli
GAGaia Maria Anelli
Gaia Maria Anelli
ICIrene Cetin
Irene Cetin

1 January 2018 in Placenta
Verified
Journal Article
Closed access
CFClaudia Fattuoni
Claudia Fattuoni
CMChiara Mandò
Chiara Mandò
FPFrancesco Palmas
Francesco Palmas
GAGaia Maria Anelli
Gaia Maria Anelli
CNChiara Novielli
Chiara Novielli
ICIrene Cetin
Irene Cetin

1 May 2013 in Current Opinion in Clinical Nutrition and Metabolic Care
Verified
Journal Article
Closed access
ICIrene Cetin
Irene Cetin
CMChiara Mandò
Chiara Mandò
SCStefania Calabrese
Stefania Calabrese
Intrauterine growth restriction (IUGR) occurs when fetal growth rate falls below the genetic potential and affects a significant number of pregnancies, but still no therapy has been developed for this pregnancy disease. This article reviews the most recent findings concerning maternal characteristics and behaviours predisposing to IUGR as well as maternal early markers of the disease. A comprehensive understanding of factors associated with IUGR will help in providing important tools for preventing and understanding adverse outcomes. Maternal nutritional status, diet and exposure to environmental factors are increasingly acknowledged as potential factors affecting fetal growth both by altering nutrient availability to the fetus and by modulating placental gene expression, thus modifying placental function. Assessing nutritional and environmental factors associated with IUGR, and the molecular mechanisms by which they may have a role in the disease onset, is necessary to provide comprehensive and common guidelines for maternal care and recommended behaviours. Moreover, maternal genetic predispositions and early serum markers may allow a better and more specific monitoring of high risk pregnancies, optimizing the timing of delivery.